[HTML][HTML] Transient plasma viral rebound after SARS-CoV-2 vaccination in an exceptional HIV-1 elite controller woman

Virology Journal, 2023 - Springer
Background Elite controllers are able to control viral replication without antiretroviral therapy.
Exceptional elite controllers do not show disease progression for more than 25 years …

[HTML][HTML] Transient Plasma Viral Rebound After Sars-cov-2 Vaccination in an Exceptional Hiv-1 Elite Controller Woman

LD Girolamo, M Ferrara, G Trevisan, BM Longo… - 2023 - europepmc.org
Background: Elite controllers are able to control viral replication without antiretroviral
therapy. Exceptional elite controllers do not show disease progression for more than 25 …

[PDF][PDF] Transient plasma viral rebound after SARS-CoV-2 vaccination in an exceptional HIV-1 elite controller woman

L Di Girolamo, M Ferrara, G Trevisan, BM Longo… - gene expression, 2023 - d-nb.info
Background Elite controllers are able to control viral replication without antiretroviral therapy.
Exceptional elite controllers do not show disease progression for more than 25 years …

[PDF][PDF] Transient plasma viral rebound after SARS-CoV-2 vaccination in an exceptional HIV-1 elite controller woman

L Di Girolamo, M Ferrara, G Trevisan, BM Longo… - gene …, 2023 - scienceopen.com
Background Elite controllers are able to control viral replication without antiretroviral therapy.
Exceptional elite controllers do not show disease progression for more than 25 years …

Transient Plasma Viral Rebound After Sars-cov-2 Vaccination in an Exceptional Hiv-1 Elite Controller Woman

L Di Girolamo, M Ferrara, G Trevisan, BM Longo… - 2023 - researchsquare.com
Background Elite controllers are able to control viral replication without antiretroviral therapy.
Exceptional elite controllers do not show disease progression for more than 25 years …

[HTML][HTML] Transient plasma viral rebound after SARS-CoV-2 vaccination in an exceptional HIV-1 elite controller woman

L Di Girolamo, M Ferrara, G Trevisan, BM Longo… - Virology …, 2023 - ncbi.nlm.nih.gov
Background Elite controllers are able to control viral replication without antiretroviral therapy.
Exceptional elite controllers do not show disease progression for more than 25 years …

Transient plasma viral rebound after SARS-CoV-2 vaccination in an exceptional HIV-1 elite controller woman

L Di Girolamo, M Ferrara, G Trevisan, BM Longo… - VIROLOGY …, 2023 - iris.unito.it
Background Elite controllers are able to control viral replication without antiretroviral therapy.
Exceptional elite controllers do not show disease progression for more than 25 years …

[HTML][HTML] Transient plasma viral rebound after SARS-CoV-2 vaccination in an exceptional HIV-1 elite controller woman

L Di Girolamo, M Ferrara, G Trevisan… - Virology …, 2023 - virologyj.biomedcentral.com
Elite controllers are able to control viral replication without antiretroviral therapy. Exceptional
elite controllers do not show disease progression for more than 25 years. Different …

Transient plasma viral rebound after SARS-CoV-2 vaccination in an exceptional HIV-1 elite controller woman

L Di Girolamo, M Ferrara, G Trevisan… - Virology …, 2023 - search.proquest.com
Background Elite controllers are able to control viral replication without antiretroviral therapy.
Exceptional elite controllers do not show disease progression for more than 25 years …

Transient plasma viral rebound after SARS-CoV-2 vaccination in an exceptional HIV-1 elite controller woman

L Di Girolamo, M Ferrara, G Trevisan… - Virology …, 2023 - pubmed.ncbi.nlm.nih.gov
Background Elite controllers are able to control viral replication without antiretroviral therapy.
Exceptional elite controllers do not show disease progression for more than 25 years …